Saturday, August 4, 2012

UPDATE 4-FDA approves Sanofi/Regeneron colon cancer drug

* Prolonged survival, delayed disease progression in trial

guelph university mba osap offices ifa qualification

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)